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In this paper, the effects of coagulation and temperature on the dielectric properties of 
human blood are investigated over the frequency range of 400 MHz - 20 GHz using 
freshly extracted blood samples. The dielectric properties are measured using blood in 
four different sample collection tubes (bottles): one containing pure whole blood, two 
containing different anticoagulant agents, and one containing clot activator and serum 
separator. The collected data indicates that additive agents can have a significant 
impact on the measured dielectric properties of blood, both immediately after the 
sample is taken, and over longer time periods. This is an important finding as it 
suggests that measurements of blood properties conducted on sample repositories, or 
tissue banks, may not be representative of natural blood properties. Further, the results 
demonstrate that the dielectric properties of normal blood vary over time due to 
coagulation. Different clotting rates lead to dielectric properties of female and male 
blood samples that vary distinctly over time. The results also show that the relative 
permittivity of the anti-coagulated blood decreases with increasing temperature, up to 
the cross-over point around 10 GHz where the trend reverses. 
   Index Terms — Dielectric measurements, biological material, Human blood, 
Coagulation, relative permittivity. 
 
1   INTRODUCTION 
 BLOOD is a complex and highly functional fluid in humans and 
other animals. The blood serves as the principle transport medium 
responsible for delivering the necessary substances such as 
nutrients, oxygen and vitamins, to vital parts of the body. It also 
transports metabolic waste products away from cells making it a 
fundamental part of the immune system [1]. Precise knowledge of 
the constituents of blood, and its physical, biological and 
chemical properties, is of great importance. In particular, the 
dielectric properties of human blood are capable of revealing a 
variety of dynamic processes and are vitally important in 
modelling of biological tissues with respect to their in vivo 
characteristics.  
The dielectric properties of blood are extremely significant in a 
multitude of medical applications. These properties are used in 
cell separation of cancer cells from normal blood cells [2]. 
Dielectric spectroscopy is used to examine the deterioration of 
preserved blood [3]. Another application of dielectric properties 
of blood is dielectric coagulometry. It can assess platelet function, 
fibrin formation, fibrinolysis and the anticoagulant effect of 
heparin [4]. Further, the dielectric response of blood can be used 
to estimate the venous thrombosis risk [5] which is the third cause 
of excess mortality in U.S. hospitals [6]. The dielectric properties 
also determine the pathways of current flow through the human 
body and are very important in the analysis of a wide range of 
biomedical applications such as functional electrical stimulation, 
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 the diagnosis and treatment of various physiological conditions 
with weak electric current currents, radio-frequency hyperthermia 
and ablation, body composition, and electrocardiography [7]–
[14]. Moreover, precise knowledge of the dielectric properties of 
blood is essential for determination and measurement of safe 
limits for electromagnetic energy absorption by the human body 
[15]–[17]. 
 
Several research studies have been performed on the dielectric 
properties of biological fluids [18]–[22]. In the past two decades, 
most published papers on the dielectric spectroscopy of blood and 
erythrocyte solutions have addressed specific aspects such as 
electrical impedance, erythrocyte suspension, polarization effect, 
and hematocrit dependency [23]–[34]. So far, the most cited work 
reporting the broadband spectra of blood covering several 
dispersion regions is by Gabriel et al. [35], taken at 37o C, which 
is commonly used for specific absorption rate (SAR) calculations 
and medical purposes. However, the available data is limited in 
scope. It does not address changes due to temperature or inter-
patient and inter-gender variability. Furthermore, the coagulation 
is not controlled for and the effect of clotted versus un-clotted 
blood on the dielectric properties is not investigated.   
 
Despite the research done so far, many aspects of the dielectric 
properties of blood are still unclear. To best of authors' 
knowledge, no study has been performed to examine the effect of 
coagulation on human blood comparing the difference in 
properties between pure blood and blood containing standard 
coagulant agents. This study aims to investigate the effects of 
coagulation and temperature on the dielectric properties of human 
blood over a broad frequency range, comparing pure blood to 
blood mixed with commonly used coagulant and anticoagulant 
agents. The measurements are performed on freshly extracted 
human blood samples. 
 
2  METHODOLOGY 
2.1 EXPERIMENTAL SET-UP 
Two sets of dielectric measurements were performed at the 
University of Malta, one to investigate the effects of 
coagulation over time and the second to investigate the effects 
of temperature. The measurements were conducted using the 
commercially available slim form probe from Keysight 
Technologies over the frequency range of 400 MHz - 20 GHz 
using 100 frequency points. The 85070E dielectric probe kit 
was connected to the Rohde & Schwarz ZVA50 vector 
network analyser (VNA). Four blood sample tubes (all 
standard plastic vacuum bottles) were used for the 
measurements: one without any added agents (i.e., containing 
pure whole blood); one with clotting gel and serum separator; 
and two with anticoagulant agents (EDTA and sodium citrate). 
These sample tubes were selected since they are the most 
commonly used in clinics and in blood tests [36], [37]. These 
sample tubes come with a colored rubber stopper to create a 
vacuum seal inside of the tube. Each tube has its own standard 
blood draw volume and is sold with a fixed amount of 
additive. For example, the standard average amount of EDTA 
is 0.1 mg for 5 mL blood. The tubes used in this study all had 
a maximum volume of 4 mL. The standard sample tube cap 
has a larger diameter (13 mm) than the diameter of the probe 
(2.2 mm). Therefore, an additional customized cap was 
designed with diameter slightly bigger than the probe; it was 
placed on the cap of the sample tube to ensure the probe was 
always in the center of the sample tube. A water bath, 
specialized beaker and water pump were used to set up an 
experimental system where measurements were performed 
using multiple sample tubes (containing the different types of 
blood samples) all at a constant temperature without moving 
the coaxial probe and cable. A customized stand was also 
designed to support the samples inside the beaker. The 
experimental set-up is shown in Figure 1. A separate 
experiment was performed to validate the temperature 
behavior of the system by placing four tubes filled with 
reference liquid into the beaker. The temperature of each tube 
was measured every 15 minutes over a period of 5 hours. The 
measured temperature of each sample was stable over this 
period, with only a slight variation of  
±0.1o C, thus validating the temperature control system.       
 
 
2.2 BLOOD SAMPLES 
Fresh blood samples from five different volunteers were 
collected by a doctor, in line with local ethical guidelines. 









Figure. 1. Photographs of the experimental set-up a) complete system 
and b) close-up of probe and the beaker containing the blood sample 
tubes. 
 into four sub-samples in order to be tested individually. The 
four sample tubes were filled up to the standard volume with 
the acquired blood sample and were immediately placed in the 
beaker with circulating water at 37 oC to maintain them at 
body temperature. 
 
2.3 EXPERIMENTAL MEASUREMENTS 
Four blood samples from different patients, one female and 
three males, were used to examine the coagulation effects over 
time. Multiple measurements were performed following the 
designed measurement protocol with the blood in each of the 
four sample tubes over a period of five and a half hours.  
First, calibration of the dielectric probe measurement system 
was performed using the standard 3-load calibration method 
(open, short, deionized water). Subsequent calibrations 
followed the same procedure. Each calibration was validated 
by performing reference measurements on 0.9% NaCl 
(physiological saline). 
To examine the measurement uncertainty of the system, 
measurements were performed on another standard reference 
material. In particular, 15 measurements were performed over 
three calibrations of the network analyzer on the reference 
material 0.1 M NaCl at 22oC. These measurements were used 
to calculate the total combined uncertainty (TCU) as in [38]. 
The TCU was calculated to be 2.1 for relative permittivity, 
and 3.4 for conductivity, demonstrating that the calibration is 
both repeatable and accurate. In Figure 2, a set of five 
calibrations is compared with the reference model of 0.9% 
NaCl from the literature [38], highlighting the repeatability 
and accuracy of the measurements. 
 
Following the calibration and validation procedures, 
measurements were taken on the blood samples. Three 
measurements were performed at each measurement instance 
and averaged to obtain one data set. Depending on the additive 
agent used, the blood may separate into the blood cells and 
plasma (especially during coagulation). Therefore, for the 
measurements of pure blood and blood with clotting gel, it 
was visually ensured that the probe was in contact with the 
region containing blood cells.  A fresh calibration was 
performed and validated using 0.9% NaCl after each set of 
measurements. The probe was cleaned using alcohol wipes 
after each measurement. The first measurement was 
performed as soon as possible and always within 20 minutes 
of extraction from the body.  
A fifth sample from a male volunteer was used to examine 
the effect of temperature on the dielectric properties of blood. 
The four tubes were filled with the blood sample and were 
gradually heated from 37 to 57 oC in 5 oC increments. Two 
sets of measurements were performed at each temperature. At 
each temperature, calibration was performed and validated 
using 0.9% NaCl solution prior to performing the blood 
measurements. 
 
3  RESULTS 
 Figure 3 shows the measured relative (real) permittivity of 
normal whole blood (without added agents) for the first four 
volunteers. The first measurement recorded from each sample 
(taken immediately after extraction) is shown in Figure 3a. 
The mean and standard deviation (STD) of all measurements, 
over the duration of 5 hours and 36 minutes from the time of 
extraction, for each sample are calculated and presented in 
Figure 3b. The error bars on each trace represent the STD. The 
plots show clear variation among the samples, which is 
expected since the composition of blood and the clotting rates 
vary naturally from patient to patient. The overall mean shows 
that the dielectric properties of the female subject's blood are 
higher than the male subjects, which agrees with other studies 
that conclude that female blood composition differs from male 
blood composition [39] and thus, it is reasonable to believe 




(a) First measurement of all samples 
 
(b) Mean and standard deviation of all measurements for each sample  
 
Figure 3. Real part of pure blood complex permittivity a) first 





Figure 2. Set of five calibrations performed using 0.9% NaCl, 
compared with the reference model of 0.9% NaCl from the literature 
[39]. 
  
Figure 3b also indicates that the dielectric properties change 
over time differently from sample to sample. For example, the 
male sample 1 measurements are consistent over time with 
small STD, whereas the male sample 2 measurements change 
significantly, by more than 5 points.  
Next, the measurements using the tube with clot activator 
and serum separator are presented in Figure 4. The 
measurements of male sample 4 were not performed due to an 
unexpected shortage of the tubes. Figure 4b shows that, unlike 
for normal blood, the mean values of all measurements over 
time for each sample are closely matched.  The female sample 
has the highest STD relative to the male samples. 
The measurements using anticoagulant agents, sodium 
citrate and EDTA, are shown in Figures 5 and 6, respectively. 
The first measurement of each sample and mean of all 
measurements for each sample, with STD as the error bars, 




Similarly, the first measurement and mean of all 
measurements for each sample using EDTA are shown in 
Figures 6a and 6b. The plots again show a clear deviation 
between the dielectric properties of female sample with the 
male samples. The dielectric properties of the male blood 
samples are close to each other, with a standard deviation 




The female sample differs from the male samples by 11-13%. 
The measurements also indicate that the difference between 
female and male blood is more than the difference between 
two or more male blood samples. One reason for this 
discrepancy is the level of coagulation of the blood - in 
 
(a) First measurement of all samples 
 
(b) Mean and standard deviation of all measurements for each sample 
 
Figure 6. Real part of complex permittivity of blood with EDTA a) first 
measurement of all samples and b) mean and standard deviation over all 
measurement times. 
 
(a) First measurement of all samples 
 
(b) Mean and standard deviation of all measurements for each sample 
 
Figure 5. Real part of complex permittivity of blood with sodium citrate 
a) first measurement of all samples and b) mean and standard deviation 
over all measurement times. 
 
(a) First measurement of all samples 
 
(b) Mean and standard deviation of all measurements for each sample 
 
Figure 4. Real part of complex permittivity of blood with clotting gel 
and serum separator a) first measurement of all samples and b) mean and 
standard deviation over all measurement times. 
 particular, the female blood was visibly not coagulating over 
time whereas the male samples were thickening. Similar 
trends have been found for the imaginary part. 
The mean and STD values of relative permittivity and 
conductivity at the start and end frequencies for all 
measurements using each type of tube are summarized in 
Tables 1 and 2. It is found that the standard deviation in the 
measurements of pure blood samples (without any added 
agents) is as large as 11%, whereas the standard deviation in 
the blood in EDTA anticoagulant is as little as 1.31% which is 
within the measurement uncertainty. These results suggest that 
the dielectric properties of blood held in tubes containing 
coagulant or anticoagulant agents may not match well with 
those of pure, untreated blood on a patient to patient basis. 
The maximum difference, across all patients, between the pure 
blood and the treated blood measurements at  








Lastly, one male blood sample was used to examine the 
effect of changing temperature on the dielectric properties of 
blood. This effect is particularly important for hyperthermia 
and ablation applications. The sample was heated in 
increments of 5o C. No clear trend with temperature was found 
for the pure blood, likely due to the variations in clotting. It 
was visually observed (through the thickening of the sample) 
that clotting had begun prior to the first set of measurements at 
body temperature; then as the sample heated the clotting 
seemed to reduce, before increasing again at higher 
temperatures. However, this lack of trend was not evident in 
treated blood samples. The real part of complex permittivity of 
blood samples with anticoagulant agents consistently 
decreases with increasing temperature, up to the cross-over 
frequency. The results are in good agreement with [1]. As an 
example, the results of heated blood sample with EDTA are 
shown in Figure 7. 
 
4  CONCLUSION 
In this paper, dielectric measurements of human blood were 
performed to investigate the effects of coagulation and 
temperature over time using four different blood sample tubes: 
one untreated containing pure whole blood, two with standard 
anticoagulant agents, and one with clot activator and serum 
separator. Four freshly extracted blood samples were used to 
examine the effect of coagulation on the dielectric properties 
over time for a frequency range of 400 MHz - 20 GHz, while 
pure blood sample was used to examine the effect of 
temperature on the dielectric properties of blood. The results 
have demonstrated that the pure blood has no clear trends in 
coagulation or temperature over time due to various patient 
dependent factors such as clotting rate, composition of blood, 
and hematocrit levels. Notably, the dielectric properties of 
pure blood differ significantly from those of blood with anti-
coagulant agent for some patients, even for measurements 
conducted on the same blood sample at the same time. This 
finding is significant as it suggests that blood dielectric 
measurements conducted on biobank or blood bank samples 
may not be representative of the natural, in-vivo variation in 
blood properties. The dielectric properties of male blood 
 
(a) Real Part of complex permittivity 
 
(b) Imaginary Part of complex permittivity 
 
Figure 7. Real and imaginary parts of complex permittivity of blood 
with EDTA with increasing temperature (the temperature values are in 
degrees Celsius). 
Table 2. Statistical information of conductivity for measurements across all 
samples using each type of sample tube. 
  Blood with 







Mean 400 MHz 1.27 1.32 1.35 1.39 
20 GHz 29.85 30.39 29.74 29.65 
STD 400 MHz 18.70% 7.57% 7.04% 6.99% 
20 GHz 20.48% 9.44% 9.91% 9.70% 
Range 400 MHz 0.95-1.66 1.08-1.48 1.22-1.6 1.31-1.68 




Table 1. Statistical information of relative permittivity for measurements 
across all samples using each type of sample tube. 
  Blood with 







Mean 400 MHz 61.99 62.50 63.44 63.10 
20 GHz 36.32 37.06 37.40 37.41 
STD 400 MHz 10.40% 6.32% 3.90% 3.90% 
20 GHz 10.73% 6.44% 3.30% 3.40% 
Range 400 MHz 53.8-72.8 49.9-68.1 58.9-70.1 61.2-70.7 




 samples are similar to each other but are clearly separated 
from the female blood sample. The relative permittivity of 
blood with anticoagulant agents decreases with increasing 
temperature, up to the crossover frequency around 10 GHz, 
while the imaginary part of the permittivity increases with 
increasing temperature up to a crossover point of ~3 GHz. 
This work suggests that a comprehensive investigation of the 
blood dielectric properties with a large number of samples is 
required to carefully investigate all confounders. As such, this 
study provides the groundwork for future studies to examine 
all aspects of the dielectric properties of human blood that 
have not been addressed before, and to build a comprehensive 
database of the properties and their dependencies.  
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